Sterotherapeutics begins Phase II trial for ST-002 targeting Cushing’s Syndrome
US-based clinical-stage company Sterotherapeutics has announced the commencement of a Phase II clinical trial for its drug candidate, ST-002, for ...
Tag: ST002
US-based clinical-stage company Sterotherapeutics has announced the commencement of a Phase II clinical trial for its drug candidate, ST-002, for ...